Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine
- 30 November 2005
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 150 (5), 1015.1-1015.e9
- https://doi.org/10.1016/j.ahj.2005.07.012
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 delivery for myocardial infarction REduction) studyAmerican Heart Journal, 2003
- Left Ventricular Remodeling After Primary Coronary AngioplastyCirculation, 2002
- Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionJournal of the American College of Cardiology, 2000
- Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of ?no reflow? phenomenonCatheterization and Cardiovascular Interventions, 2000
- Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarctionThe American Journal of Cardiology, 2000
- Beneficial Effects of Intracoronary Adenosine as an Adjunct to Primary Angioplasty in Acute Myocardial InfarctionCirculation, 2000
- Myocardial Perfusion Patterns Related to Thrombolysis in Myocardial Infarction Perfusion Grades After Coronary Angioplasty in Patients With Acute Anterior Wall Myocardial InfarctionCirculation, 1996
- Clinical Implications of the ‘No Reflow’ PhenomenonCirculation, 1996
- Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.Circulation, 1994
- Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.Circulation, 1992